Rigel Pharmaceuticals, Inc. (RIGL): Price and Financial Metrics

RIGL POWR Grades

• Value is the dimension where RIGL ranks best; there it ranks ahead of 86.29% of US stocks.
• RIGL's strongest trending metric is Value; it's been moving up over the last 179 days.
• RIGL's current lowest rank is in the Stability metric (where it is better than 0.99% of US stocks).

RIGL Stock Summary

• RIGEL PHARMACEUTICALS INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 2.92% of US listed stocks.
• RIGL's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 2.62% of US stocks.
• Revenue growth over the past 12 months for RIGEL PHARMACEUTICALS INC comes in at 52.53%, a number that bests 88.06% of the US stocks we're tracking.
• Stocks with similar financial metrics, market capitalization, and price volatility to RIGEL PHARMACEUTICALS INC are PLTK, QMCO, INTZ, WEJO, and AVID.
• RIGL's SEC filings can be seen here. And to visit RIGEL PHARMACEUTICALS INC's official web site, go to www.rigel.com.

RIGL Valuation Summary

• RIGL's price/sales ratio is 1.9; this is 62.75% lower than that of the median Healthcare stock.
• RIGL's price/earnings ratio has moved down 3.9 over the prior 243 months.

Below are key valuation metrics over time for RIGL.

RIGL Growth Metrics

Its year over year cash and equivalents growth rate is now at 23.11%.
• Its 2 year cash and equivalents growth rate is now at -45.43%.
• Its year over year revenue growth rate is now at -36.54%.

RIGL's revenue has moved up $30,085,000 over the prior 33 months.

The table below shows RIGL's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	89.373	-70.935	-82.615
2022-06-30	88.506	-67.931	-84.53
2022-03-31	84.953	0.196	-84.859
2021-12-31	149.236	5.878	-17.914
2021-09-30	147.277	9.392	-14.51
2021-06-30	144.123	0.207	-7.732

RIGL's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• RIGL has a Quality Grade of B, ranking ahead of 89.87% of graded US stocks.
• RIGL's asset turnover comes in at 0.825 -- ranking 30th of 682 Pharmaceutical Products stocks.
• GERN, NEOG, and VNDA are the stocks whose asset turnover ratios are most correlated with RIGL.

The table below shows RIGL's key quality metrics over time.